{
  "author": {
    "name": "Peter Vercoe",
    "webUrl": "/author/profile/peter-vercoe/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2018/03/08/cigna-to-acquire-express-scripts-as-health-shakeou/",
        "title": "Cigna to buy Express Scripts as health shakeout speeds up",
        "byline": "Robert Langreth and Peter Vercoe",
        "kicker": "",
        "prettyDate": "March 08, 2018",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/03/0615cigna_ap-e1520521890865.jpg",
          "width": "650",
          "height": "433"
        },
        "authors": [
          {
            "webUrl": "/author/profile/robert-langreth/",
            "name": "Robert Langreth"
          },
          {
            "webUrl": "/author/profile/peter-vercoe/",
            "name": "Peter Vercoe"
          }
        ],
        "kickerNode": [],
        "summary": "Cigna's deal was prompted by high drug costs; Express Scripts is the largest remaining independent drug middleman.",
        "body": null
      }
    ]
  }
}